Chung Hwa Chemical Industrial Works, Ltd. Stocks

NT$ 73.8Last Updated 27.04.2026

Issuer Rating

2/7
Performance

Poor

Risk

Moderate

Recommendation

Sell

Market Cap

NT$ 300.35M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 73.8
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Chung Hwa Chemical Industrial Works, Ltd. engages in the manufacture and sale of chemical products in Taiwan and internationally. The company provides basic chemicals, including acids, alkalis, and phosphates for use in water treatment, detergent, papermaking, textiles, PCB, etc.; and specialty chemicals, such as reactive UV absorbers, polymer additives, sulfonated monomers, catalysts, thermal paper materials, and surface active agents for dyes, plastics, chemical textiles, IC wafers, display panels, electronics, photoelectric markets, etc. It also offers electronic chemicals, which include Saint-Gobain process fluid systems that are used in etching liquid cleaning in electronics industry and liquid transport equipment in electronic factories; and water treatment and biomass chemicals. The company was founded in 1956 and is based in Taoyuan City, Taiwan.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks